305 related articles for article (PubMed ID: 15986133)
1. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
3. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
4. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
5. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
Uhlenbrock K; Eberth A; Herbrand U; Daryab N; Stege P; Meier F; Friedl P; Collard JG; Ahmadian MR
J Cell Sci; 2004 Sep; 117(Pt 20):4863-71. PubMed ID: 15340013
[TBL] [Abstract][Full Text] [Related]
6. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
7. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
Swart GW
Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
[TBL] [Abstract][Full Text] [Related]
8. Integrin signaling in malignant melanoma.
Kuphal S; Bauer R; Bosserhoff AK
Cancer Metastasis Rev; 2005 Jun; 24(2):195-222. PubMed ID: 15986132
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.
von Lersner A; Droesen L; Zijlstra A
Clin Exp Metastasis; 2019 Apr; 36(2):87-95. PubMed ID: 30778704
[TBL] [Abstract][Full Text] [Related]
10. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
[TBL] [Abstract][Full Text] [Related]
11. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
12. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
Hong X; Michalski CW; Kong B; Zhang W; Raggi MC; Sauliunaite D; De Oliveira T; Friess H; Kleeff J
J Surg Oncol; 2010 Jun; 101(7):564-9. PubMed ID: 20461761
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
van Kempen LC; van den Oord JJ; van Muijen GN; Weidle UH; Bloemers HP; Swart GW
Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
[TBL] [Abstract][Full Text] [Related]
14. Role of integrins and other cell adhesion molecules in tumor progression and metastasis.
Albelda SM
Lab Invest; 1993 Jan; 68(1):4-17. PubMed ID: 8423675
[TBL] [Abstract][Full Text] [Related]
15. JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling.
Bai J; Zhang J; Wu J; Shen L; Zeng J; Ding J; Wu Y; Gong Z; Li A; Xu S; Zhou J; Li G
Oncogene; 2010 Feb; 29(8):1227-37. PubMed ID: 19946336
[TBL] [Abstract][Full Text] [Related]
16. Clinical, cellular, and molecular aspects of cancer invasion.
Mareel M; Leroy A
Physiol Rev; 2003 Apr; 83(2):337-76. PubMed ID: 12663862
[TBL] [Abstract][Full Text] [Related]
17. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.
Kristiansen G; Pilarsky C; Wissmann C; Stephan C; Weissbach L; Loy V; Loening S; Dietel M; Rosenthal A
Prostate; 2003 Jan; 54(1):34-43. PubMed ID: 12481253
[TBL] [Abstract][Full Text] [Related]
18. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
[TBL] [Abstract][Full Text] [Related]
19. [Biological basis of metastasis formation].
Smolle J
Hautarzt; 1992 Feb; 43(2):55-64. PubMed ID: 1548129
[TBL] [Abstract][Full Text] [Related]
20. Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy.
Te Riet J; Zimmerman AW; Cambi A; Joosten B; Speller S; Torensma R; van Leeuwen FN; Figdor CG; de Lange F
J Cell Sci; 2007 Nov; 120(Pt 22):3965-76. PubMed ID: 17971418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
